Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1184-1190

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halvorsen, B.
Right arrow Articles by Ranheim, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halvorsen, B.
Right arrow Articles by Ranheim, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Hazardous Substances DB
*PROSTAGLANDIN F2ALPHA
Related Collections
Right arrow Lipids
Right arrow Cell biology/structural biology
Right arrow Gene regulation
Right arrow Other arteriosclerosis
Right arrow Oxidant stress
Right arrow Other Vascular biology

(Hypertension. 2001;37:1184.)
© 2001 American Heart Association, Inc.


Scientific Contribution

8-iso-Prostaglandin F2{alpha} Increases Expression of LOX-1 in JAR Cells

Bente Halvorsen; Anne Cathrine Staff; Tore Henriksen; Tatsuya Sawamura; Trine Ranheim

From the Institute for Nutrition Research (B.H., A.C.S., T.H., T.R.), Faculty of Medicine, University of Oslo; Departments of Obstetrics and Gynecology (A.C.S.), Aker University Hospital; and Departments of Obstetrics and Gynecology (T.H.), National Hospital, University of Oslo, Norway; and Department of Bioscience (T.S.), National Cardiovascular Center Research Institute, Suita, Osaka, Japan. Dr Halvorsen is currently with the Research Institute for Internal Medicine, National Hospital, University of Oslo, Norway.

Correspondence to Bente Halvorsen, PhD, Research Institute for Internal Medicine, National Hospital, University of Oslo, 0027 Oslo, Norway. E-mail bente.halvorsen{at}klinmed.uio.no

Abstract—Lectinlike oxidized LDL receptor-1 (LOX-1), a cell-surface receptor for oxidized LDL (ox-LDL), is proposed to be involved in endothelial dysfunction and in the pathogenesis of atherosclerosis. Preeclampsia is a pregnancy complication diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues. A feature of preeclampsia is formation of foam cells in maternal arterial walls of gestational tissue ("acute atherosis"). Oxidative stress is believed to play a role in the pathophysiology of preeclampsia. 8-iso-prostaglandin F2{alpha} (8-iso-PGF2{alpha}) is a marker of oxidative stress in vivo, is biologically active in vitro, and is elevated in preeclamptic plasma and gestational tissue. In the present article, we hypothesized that 8-iso-PGF2{alpha} could induce the expression of LOX-1 in trophoblastic cells (JAR). We demonstrated augmented cellular uptake of 125I-tyraminylcellobiose ox-LDL in JAR cells incubated with 8-iso-PGF2{alpha} (10 µmol/L) versus control cells. Ligand blots revealed an increased binding of ox-LDL to LOX-1 in JAR cells incubated with 8-iso-PGF2{alpha} (10 µmol/L). Incubation with 8-iso-PGF2{alpha} (10 µmol/L) also resulted in augmented LOX-1 protein levels (Western blots) and mRNA levels (Northern blots). JAR cells transfected with 3 copies of a nuclear factor-{kappa}B binding site demonstrated dose-dependent activation of the reporter gene luciferase after incubation with 8-iso-PGF2{alpha} (0 to 10 µmol/L). We also demonstrated increased accumulation of neutral fats in JAR cells incubated with 8-iso-PGF2{alpha} (10 µmol/L) and ox-LDL compared with controls by oil red O staining. We speculate a potential role of isoprostanes and LOX-1 in preeclampsia in the development of "acute atherosis" of gestational spiral arteries.


Key Words: receptors, lipoprotein • isoprostanes • nuclear factor • trophoblast • preeclampsia




This article has been cited by other articles:


Home page
ReproductionHome page
M Ethier-Chiasson, J-C Forest, Y Giguere, A Masse, C Marseille-Tremblay, E Levy, and J Lafond
Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies
Reproduction, October 1, 2008; 136(4): 491 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Halvorsen, T. Waehre, H. Scholz, O. P. Clausen, J. H. von der Thusen, F. Muller, H. Heimli, S. Tonstad, C. Hall, S. S. Froland, et al.
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
J. Lipid Res., February 1, 2005; 46(2): 211 - 219.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier
Lipids from Oxidized Low-Density Lipoprotein Modulate Human Trophoblast Invasion: Involvement of Nuclear Liver X Receptors
Endocrinology, October 1, 2004; 145(10): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Scholz, A. Yndestad, J. K. Damas, T. Waehre, S. Tonstad, P. Aukrust, and B. Halvorsen
8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
Cardiovasc Res, October 1, 2003; 59(4): 945 - 954.
[Abstract] [Full Text] [PDF]